These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35263272)

  • 1. Comment: Introducing Neuromodulation in 2035: Future Forecasting Series.
    Jones LK; Gross RA
    Neurology; 2022 Jan; 98(2):64. PubMed ID: 35263272
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuromodulation for Pain Treatment: Building a Foundation for Future Study.
    Sivanesan E; Cohen SP
    Anesthesiology; 2020 Aug; 133(2):262-264. PubMed ID: 32568851
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuromodulation for lower urinary tract dysfunction--an update.
    Hussain Z; Harrison SC
    ScientificWorldJournal; 2007 Jun; 7():1036-45. PubMed ID: 17619785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The future of invasive neuromodulation: new techniques and expanded indications].
    van Ophoven A; Pannek J
    Urologe A; 2012 Feb; 51(2):212-6. PubMed ID: 22269995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolving definition of neuromodulation.
    Levy RM
    Neuromodulation; 2014 Apr; 17(3):207-10. PubMed ID: 24773384
    [No Abstract]   [Full Text] [Related]  

  • 6. Comment on: "Device Outcomes in Pediatric Sacral Neuromodulation: A Single Center Series of 187 patients".
    Casal-Beloy I; García González M; García-Novoa MA; Argibay IS
    J Pediatr Urol; 2021 Feb; 17(1):73-74. PubMed ID: 33279433
    [No Abstract]   [Full Text] [Related]  

  • 7. The International Functional Electrical Stimulation Society (IFESS): Current and future developments.
    Street T; Yoshida K; Spaich EG; Milosevic M
    Artif Organs; 2022 Oct; 46(10):1968-1969. PubMed ID: 35690895
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comment to W. Otto et al. Sacral neuromodulation as second-line treatment strategy].
    Gabuev A
    Aktuelle Urol; 2012 May; 43(3):167. PubMed ID: 22639026
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial Comment: Sacral neuromodulation versus onabotulinumtoxinA for refractory urgency urinary incontinence: impact on fecal incontinence symptoms and sexual function.
    Riccetto CLZ
    Int Braz J Urol; 2020; 46(4):671-672. PubMed ID: 32374138
    [No Abstract]   [Full Text] [Related]  

  • 10. Is there a future for electrophysical agents in musculoskeletal physiotherapy?
    Chipchase L
    Man Ther; 2012 Aug; 17(4):265-6. PubMed ID: 22542161
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial Comment to Sacral neuromodulation is an effective option for non-obstructive urinary retention in men with cerebral palsy.
    Yamamoto T; Gotoh M
    Int J Urol; 2014 Apr; 21(4):431. PubMed ID: 24812688
    [No Abstract]   [Full Text] [Related]  

  • 12. A neuromodulation call to arms.
    Hagedorn JM
    Reg Anesth Pain Med; 2019 Apr; 44(4):532. PubMed ID: 30914476
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neuromodulation in the management of neurogenic lower urinary tract dysfunction].
    Keppene V; Mozer P; Chartier-Kastler E; Ruffion A
    Prog Urol; 2007 May; 17(3):609-15. PubMed ID: 17622098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is sertraline plus transcranial direct current stimulation the future of effective depression treatment?
    Shiozawa P; Cordeiro Q; Fregni F; Brunoni AR
    J Comp Eff Res; 2013 May; 2(3):213-5. PubMed ID: 24236617
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial Comment: Systematic Literature Review and Meta-Analysis of Sacral Neuromodulation (SNM) in Patients with Neurogenic Lower Urinary Tract Dys-function (nLUTD): Over 20 Years' Experience and Fu-ture Directions.
    Averbeck MA
    Int Braz J Urol; 2021; 47(6):1264-1265. PubMed ID: 34469676
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential of Electrical Neuromodulation for Inflammatory Bowel Disease.
    Cheng J; Shen H; Chowdhury R; Abdi T; Selaru F; Chen JDZ
    Inflamm Bowel Dis; 2020 Jul; 26(8):1119-1130. PubMed ID: 31782957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Evolution of Neuromodulation in the Treatment of Chronic Pain: Forward-Looking Perspectives.
    Fishman MA; Antony A; Esposito M; Deer T; Levy R
    Pain Med; 2019 Jun; 20(Suppl 1):S58-S68. PubMed ID: 31152176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial comment re: Killinger et al. "Secondary changes in bowel function after successful treatment of voiding symptoms with neuromodulation".
    van Kerrebroeck P
    Neurourol Urodyn; 2011 Sep; 30(7):1403. PubMed ID: 21538494
    [No Abstract]   [Full Text] [Related]  

  • 19. Spinal cord stimulation: principles of past, present and future practice: a review.
    Kunnumpurath S; Srinivasagopalan R; Vadivelu N
    J Clin Monit Comput; 2009 Oct; 23(5):333-9. PubMed ID: 19728120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current use of neuromodulation for bladder dysfunction.
    Sherman ND; Amundsen CL
    Minerva Ginecol; 2006 Aug; 58(4):283-93. PubMed ID: 16957672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.